Overview

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and weight loss when sibutramine is used in overweight and obese subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Abbott
Treatments:
Sibutramine